azacitidine and fazarabine

azacitidine has been researched along with fazarabine in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-199021 (45.65)18.7374
1990's24 (52.17)18.2507
2000's1 (2.17)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbasi, MM; Beisler, JA; Driscoll, JS1
Abbruzzese, JL; Frost, P1
Abbruzzese, JL; Ajani, JA; Daugherty, K; Hubbard, KP; Levin, B; Pazdur, R1
Esparza, L; Holmes, FA; Hortobagyi, GN; Theriault, RL; Walters, RS1
Amato, R; Ho, D; Krakoff, IH; Raber, M; Schmidt, S1
Casper, ES; Kelsen, DP; Schwartz, GK1
McCulloch, EA; Yang, GS1
Ben-Baruch, N; Cowan, KH; Fine, R; Ford, H; Kelley, JA; Surbone, A; Thomas, RV1
Allegra, CJ; Grem, JL2
Alberti, D; Arzoomanian, RZ; Bailey, H; Bruggink, J; Tombes, MB; Tutsch, KD; Wilding, G1
Brown, TD; Burris, HA; Havlin, KA; O'Rourke, TJ; Rodriguez, GI; Wall, JG; Weiss, GR1
Hynes, HE; Keppen, M; Kuebler, JP; Metch, B; Schuller, DE1
Cheng, YC; Cooney, D; Dutschman, G; Leclerc, JM; Townsend, A1
Breitman, TR; Cooney, DA; Dalal, M; del Campo, AA; Driscoll, JS; Johns, DG; Plowman, J; Schuller, HM; Vistica, DT1
Veselý, J1
Covey, JM; Zaharko, DS1
Driscoll, JS; Johns, DG; Plowman, J1
Pískala, A; Veselý, J1
Cihák, A; Skoda, J; Vesely, J1
Ahluwalia, GS; Arnold, ST; Balzarini, J; Cohen, MB; Cooney, DA; Dalal, M; Johns, DG; Kang, GJ; McMahon, JB; Wilson, YA1
Bhalla, K; Gleyzer, M; Grant, S1
Antonsson, BE; Avramis, VI; Holcenberg, JS; Nyce, J1
Cheng, YC; Townsend, AJ1
Arlin, Z; Baker, M; Bhalla, K; Cole, J; Graham, G; Grant, S; MacLaughlin, W1
Cradock, JC; Grem, JL; Grieshaber, CK; Harrison, SD; Hoth, DF; King, SA; Leyland-Jones, B; Plowman, J; Shoemaker, DD; Zaharko, D1
Balis, FM; Heideman, RL; McCully, C; Poplack, DG1
Balis, FM; Ettinger, LJ; Ford, H; Gillespie, A; Heideman, RL; Packer, RJ; Poplack, DG; Reaman, GH; Sato, J; Tan, C1
Avramis, VI; Mecum, RA; Powell, WC1
Durr, FE; Lindh, D; Wallace, RE1
Asofsky, R; Hirschhorn, R; Kim, J; Ratech, H; Thorbecke, GJ1
Glazer, RI; Knode, MC1
Mojaverian, P; Repta, AJ1
Crowley, JJ; Goodwin, JW; Livingston, RB; Panella, TJ; Williamson, SK1
Novotný, L; Pískala, A; Vachálková, A1
Bernstein, ML; Devine, S; Dubowy, R; Grier, H; Kung, F; Land, V; Murphy, S; Whitehead, VM1
Eyre, HJ; Selby, GB; Townsend, J; Upchurch, C1
Blessing, JA; Look, KY; Manetta, A1
Avramis, VI; Kees, UR1
Blessing, JA; Manetta, A; Mann, WJ; Smith, DM1
Cowan, KH; Johnston, PG; Kleiner, D1
Ben-Baruch, N; Cowan, KH; Denicoff, AM; Goldspiel, BR; O'Shaughnessy, JA1
Ahluwalia, GS; Barchi, JJ; Cooney, DA; Covey, JM; Gharehbaghi, K; Hochman, I; Jayaram, HN; Paull, KD1
Ames, MM; Erlichman, C; Fitch, TR; Goldberg, RM; Kuffel, MJ; Reid, JM; Rubin, J; Sloan, JA1
Estey, E; Kantarjian, HM; Keating, MJ; O'Brien, S; Plunkett, W; Rios, MB; Sorenson, M; Wilhelm, M1
Krynetskaia, NF; Krynetskiy, E; Mishra, AK; Phadke, MS1

Reviews

4 review(s) available for azacitidine and fazarabine

ArticleYear
New anticancer agents.
    Cancer chemotherapy and biological response modifiers, 1991, Volume: 12

    Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Biphenyl Compounds; Chrysenes; Deoxycytidine; Echinomycin; Epirubicin; Etanidazole; Flavonoids; Gemcitabine; Guanidines; Humans; Idarubicin; Menogaril; Mitoguazone; Neoplasms; Nitroimidazoles; Nogalamycin; Organoplatinum Compounds; Paclitaxel; Pentostatin; Polymers; Propylene Glycols; Ribavirin; Sulfonylurea Compounds; Trimetrexate; Vidarabine Phosphate

1991
Mode of action and effects of 5-azacytidine and of its derivatives in eukaryotic cells.
    Pharmacology & therapeutics, 1985, Volume: 28, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cells; Cytidine; Drug Resistance; Enzyme Activation; Eukaryotic Cells; Humans; Leukemia, Experimental; Liver Regeneration; Uridine Kinase

1985
Azapyrimidine nucleosides: metabolism and inhibitory mechanisms.
    Advances in enzyme regulation, 1985, Volume: 24

    Topics: Animals; Antineoplastic Agents; Azacitidine; Azauridine; Decitabine; DNA; Gastric Mucosa; Leukemia, Experimental; Mice; Rats; RNA, Ribosomal

1985
Arabinosyl-5-azacytosine: a novel nucleoside entering clinical trials.
    Investigational new drugs, 1987, Volume: 5, Issue:4

    Topics: Antiviral Agents; Azacitidine; Humans

1987

Trials

16 trial(s) available for azacitidine and fazarabine

ArticleYear
Phase II trial of fazarabine in advanced colorectal carcinoma.
    Investigational new drugs, 1992, Volume: 10, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Carcinoma; Colorectal Neoplasms; Drug Administration Schedule; Drug Evaluation; Humans; Male; Middle Aged

1992
Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer.
    Investigational new drugs, 1992, Volume: 10, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Breast Neoplasms; Carcinoma; Drug Evaluation; Female; Humans; Middle Aged

1992
Phase I trial of a 72-h continuous-infusion schedule of fazarabine.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms

1992
Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma.
    Investigational new drugs, 1992, Volume: 10, Issue:3

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Azacitidine; Female; Humans; Infusion Pumps; Male; Middle Aged; Pancreatic Neoplasms

1992
Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272).
    Cancer research, 1990, Feb-15, Volume: 50, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia

1990
Phase I clinical trial of fazarabine as a twenty-four-hour continuous infusion.
    Cancer research, 1991, Feb-15, Volume: 51, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Metabolic Clearance Rate; Middle Aged; Neoplasms

1991
Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.
    Investigational new drugs, 1991, Volume: 9, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged

1991
Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: a Southwest Oncology Group study.
    Investigational new drugs, 1995, Volume: 13, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged

1995
A phase I trial of fazarabine in refractory pediatric solid tumors. A Pediatric Oncology Group study.
    Investigational new drugs, 1993, Volume: 11, Issue:4

    Topics: Antineoplastic Agents; Azacitidine; Child; Child, Preschool; Drug Administration Schedule; Humans; Neoplasms

1993
A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study.
    Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Azacitidine; Brain Neoplasms; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Southwestern United States; Treatment Failure

1994
A phase II study of fazarabine in patients with advanced ovarian cancer. A Gynecologic Oncology Group study.
    American journal of clinical oncology, 1995, Volume: 18, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Agents; Azacitidine; Female; Humans; Infusions, Intravenous; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome

1995
A phase II study of fazarabine (NSC 281272) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
    American journal of clinical oncology, 1995, Volume: 18, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Carcinoma, Squamous Cell; Female; Humans; Middle Aged; Uterine Cervical Neoplasms

1995
Fazarabine: a report of response in a patient with multiply relapsed embryonal cell carcinoma.
    American journal of clinical oncology, 1993, Volume: 16, Issue:1

    Topics: Adult; Antineoplastic Agents; Azacitidine; Humans; Male; Neoplasms, Germ Cell and Embryonal

1993
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer.
    Investigational new drugs, 1993, Volume: 11, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Azacitidine; Colonic Neoplasms; Drugs, Investigational; Female; Humans; Infusions, Intravenous; Male; Middle Aged

1993
Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factor.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:12 Pt 1

    Topics: Adult; Antineoplastic Agents; Azacitidine; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Metabolic Clearance Rate; Nausea; Neoplasms; Neutropenia

1997
Phase I study of arabinosyl-5-azacytidine (fazarabine) in adult acute leukemia and chronic myelogenous leukemia in blastic phase.
    Leukemia & lymphoma, 1999, Volume: 34, Issue:5-6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Azacitidine; Blast Crisis; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Treatment Outcome

1999

Other Studies

26 other study(ies) available for azacitidine and fazarabine

ArticleYear
Synthesis and antitumor activity of 5-azacytosine arabinoside.
    Journal of medicinal chemistry, 1979, Volume: 22, Issue:10

    Topics: Animals; Antineoplastic Agents; Azacitidine; Chemical Phenomena; Chemistry; Leukemia L1210; Mice; Stereoisomerism

1979
Studies on the mechanism of the synergistic interaction between 2'-deoxy-5-azacytidine and cisplatin.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cisplatin; Decitabine; DNA, Neoplasm; Drug Resistance; Drug Synergism; Humans; Melanoma; Methylation; Mice; Sensitivity and Specificity; Tubercidin; Tumor Cells, Cultured

1992
A comparison of the lethal effects in culture of cytosine arabinoside and arabinofuranosyl-5-azacytosine acting on the blast cells fo acute myeloblastic leukemia.
    Hematologic pathology, 1992, Volume: 6, Issue:3

    Topics: Acute Disease; Antineoplastic Agents; Azacitidine; Blast Crisis; Cell Survival; Cytarabine; Humans; Leukemia, Myeloid; Tumor Cells, Cultured

1992
Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
    Cancer research, 1990, Nov-15, Volume: 50, Issue:22

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Survival; Colorectal Neoplasms; Cytarabine; Cytidine Triphosphate; Deoxycytosine Nucleotides; DNA, Neoplasm; Humans; In Vitro Techniques; Tumor Cells, Cultured

1990
Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine.
    Biochemical pharmacology, 1991, Jul-05, Volume: 42, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Division; Cell Line; Cell Nucleus; Cell Survival; Colonic Neoplasms; Cytarabine; Cytidine; Deoxycytosine Nucleotides; DNA, Neoplasm; Drug Administration Schedule; Drug Interactions; Fluorouracil; Humans; Nucleic Acids; Thymine Nucleotides; Tumor Stem Cell Assay

1991
Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).
    Cancer research, 1985, Volume: 45, Issue:8

    Topics: Antineoplastic Agents; Azacitidine; Cells, Cultured; DCMP Deaminase; Deoxycytidine Kinase; DNA; Drug Stability; Humans; Kinetics; Stereoisomerism; Structure-Activity Relationship; T-Lymphocytes; Tritium

1985
Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties.
    Cancer research, 1986, Volume: 46, Issue:2

    Topics: Animals; Azacitidine; Cell Cycle; Cell Differentiation; Cell Survival; Cells, Cultured; Humans; Mice; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Vidarabine

1986
Arabinosyl-5-azacytosine: plasma kinetics and therapeutic response (L1210) in vitro and in vivo in mice.
    Investigational new drugs, 1985, Volume: 3, Issue:4

    Topics: Animals; Antineoplastic Agents; Azacitidine; Cells, Cultured; Decitabine; Kinetics; Leukemia L1210; Male; Mice; Mice, Inbred Strains

1985
Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia.
    Investigational new drugs, 1985, Volume: 3, Issue:4

    Topics: Animals; Antineoplastic Agents; Azacitidine; Brain Neoplasms; Carmustine; Cytarabine; Leukemia L1210; Mice; Mice, Inbred Strains; Neoplasm Transplantation

1985
Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells.
    Neoplasma, 1986, Volume: 33, Issue:1

    Topics: Animals; Antineoplastic Agents; Azacitidine; Bone Marrow; Bone Marrow Cells; Cell Division; Cell Line; Cell Survival; Cytarabine; Decitabine; Drug Evaluation, Preclinical; Kinetics; Leukemia L1210; Leukocyte Count; Male; Mice; Mice, Inbred DBA; Nucleosides; Phosphorylation; Thymidine

1986
Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.
    Cancer research, 1986, Volume: 46, Issue:9

    Topics: Animals; Azacitidine; Biological Transport; Colonic Neoplasms; Cytidine; Deoxycytidine; Deoxycytidine Kinase; DNA; Drug Resistance; Humans; Leukemia P388; Mice; Phosphorylation

1986
Interaction of deoxycytidine and deoxycytidine analogs in normal and leukemic human myeloid progenitor cells.
    Leukemia research, 1986, Volume: 10, Issue:9

    Topics: Azacitidine; Cell Division; Cell Line; Colony-Forming Units Assay; Cytarabine; Decitabine; Deoxycytidine; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute

1986
Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1.
    Cancer research, 1987, Jul-15, Volume: 47, Issue:14

    Topics: Azacitidine; Cell Line; Cytarabine; Decitabine; Deoxycytidine Kinase; DNA; DNA (Cytosine-5-)-Methyltransferases; Drug Resistance; Humans; Lymphoid Tissue; Methylation; Phosphotransferases

1987
Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.
    Molecular pharmacology, 1987, Volume: 32, Issue:3

    Topics: Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Azacitidine; Base Sequence; Cell Line; DNA; DNA Polymerase I; DNA Polymerase II; Humans; Kinetics; Templates, Genetic

1987
Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
    Leukemia, 1987, Volume: 1, Issue:12

    Topics: Acute Disease; Azacitidine; Bone Marrow; Decitabine; Deoxycytidine; Deoxycytosine Nucleotides; DNA, Neoplasm; Hematopoietic Stem Cells; Humans; Leukemia; Neoplastic Stem Cells

1987
Preclinical pharmacology of arabinosyl-5-azacytidine in nonhuman primates.
    Cancer research, 1988, Aug-01, Volume: 48, Issue:15

    Topics: Animals; Antineoplastic Agents; Azacitidine; Drug Evaluation, Preclinical; Half-Life; Macaca mulatta; Male; Mathematics

1988
Phase I trial and pharmacokinetic evaluation of fazarabine in children.
    Cancer research, 1989, Sep-15, Volume: 49, Issue:18

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Child; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Neoplasms

1989
Cellular metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA and RNA of human lymphoid CEM/0 and CEM/dCk(-) cells.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:1

    Topics: Antineoplastic Agents; Azacitidine; Cell Line; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Leukemia; Methylation; RNA, Neoplasm; Stereoisomerism; Time Factors; Tritium; Tumor Cells, Cultured

1989
Arabinofuranosyl-5-azacytosine: activity against human tumors in athymic mice.
    Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:2

    Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Transformation, Neoplastic; Cytarabine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Stereoisomerism; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured

1989
Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
    Journal of immunology (Baltimore, Md. : 1950), 1984, Volume: 132, Issue:6

    Topics: Adenosine Deaminase; Animals; Azacitidine; Body Weight; Coformycin; Deoxyadenosines; DNA; Lymphoma; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Neoplasm Transplantation; Nucleoside Deaminases; Organ Size; Pentostatin; Phenotype; Ribonucleosides; Spleen; T-Lymphocytes; Thymus Gland

1984
1-beta-D-arabinosyl-5-azacytosine. Cytocidal activity and effects on the synthesis and methylation of DNA in human colon carcinoma cells.
    Molecular pharmacology, 1984, Volume: 26, Issue:2

    Topics: Azacitidine; Cell Line; Cell Survival; Colonic Neoplasms; DNA, Neoplasm; Humans; Kinetics; Methylation; Stereoisomerism

1984
Development of an intravenous formulation for the unstable investigational cytotoxic nucleosides 5-azacytosine arabinoside (NSC 281272) and 5-azacytidine (NSC 102816).
    The Journal of pharmacy and pharmacology, 1984, Volume: 36, Issue:11

    Topics: Antineoplastic Agents; Azacitidine; Benzoates; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Diethylhexyl Phthalate; Drug Incompatibility; Drug Stability; Injections, Intravenous; Plasticizers; Solubility

1984
Polarographic reduction and carcinogenic index tg alpha of 5-aza nucleosides possessing antileukemic activity.
    Neoplasma, 1993, Volume: 40, Issue:5

    Topics: Antineoplastic Agents; Azacitidine; Carcinogens; Cytarabine; Cytidine; Molecular Structure; Oxidation-Reduction; Polarography; Structure-Activity Relationship

1993
Biochemical pharmacology and DNA methylation studies of arabinosyl 5-azacytidine and 5,6-dihydro-5-azacytidine in two human leukemia cell lines PER-145 and PER-163.
    Anti-cancer drugs, 1995, Volume: 6, Issue:2

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; DNA; Humans; Leukemia; Methylation; Tumor Cells, Cultured

1995
Studies on the mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine (fazarabine) in mammalian lymphoblasts.
    Journal of experimental therapeutics & oncology, 1996, Volume: 1, Issue:3

    Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Survival; Deoxycytidine; DNA, Neoplasm; Humans; Leukemia P388; Lymphocytes; Mice; Mice, Inbred Strains; Phosphorylation; Tumor Cells, Cultured

1996
Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:1

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Lung Neoplasms

2009